Gankyrin has been shown to upregulate IGFBP5 expression in Huh-7 human hepatocellular carcinoma (HCC) and U-2 OS osteosarcoma cell lines (197). The gene discussed is IGFBP5; the disease is hepatocellular carcinoma.